Brigatinib (Alunbrig), also known as brigatinib, is a targeted therapy with the active ingredient brigatinib, commonly formulated as film-coated tablets.
2026 Price of Brigatinib (Alunbrig) per Box
The Lao Da Xiong version of brigatinib is available in two strengths, with reference prices as follows (for reference only):
90 mg * 21 tablets per box: approximately 50 US dollars per box
180 mg * 21 tablets per box: approximately 79 US dollars per box
Proper Storage of Brigatinib (Alunbrig) After Purchase
Storage Environment Requirements
1.Temperature Control: Store at room temperature, specifically between 20°C and 25°C.
2.Avoid Extreme Conditions: Do not place brigatinib in bathrooms or vehicles, where it may be exposed to excessive heat or cold.
3.Moisture Protection: Keep the brigatinib bottle in a dry location to prevent contact with moisture.
Daily Management Tips
1.Original Packaging: Keep tablets in their original bottle; do not transfer them to other containers.
2.Keep Away from Children: Store brigatinib in a location inaccessible and out of sight of children.
3.Check Expiry Date: Regularly inspect the expiration date of brigatinib. Expired medications should be disposed of properly and must not be used.
Precautions for Specific Patient Groups Taking Brigatinib (Alunbrig)
Patients with Specific Health Conditions
1.Lung Disease: Use with caution in patients with a history of interstitial lung disease or pneumonia.
2.Hypertension: Brigatinib may cause elevated blood pressure. Regular monitoring is required, and antihypertensive medication may be necessary.
3.Liver Disease: Dose adjustments may be required based on the severity of hepatic impairment.
Use in Special Populations
1.Pregnant Women: Brigatinib may cause fetal harm. Women of childbearing potential must use effective contraception during treatment.
2.Lactating Women: Breastfeeding should be discontinued during treatment and for one week after the last dose.
3.Elderly Patients: The safety and efficacy of brigatinib are similar between elderly and younger patients. Use as directed by a physician.
Patients on Concomitant Medications
1.CYP3A Inhibitors: Certain antifungals and antibiotics may increase the plasma concentration of brigatinib.
2.CYP3A Inducers: Certain antiepileptics and rifampicin may reduce the efficacy of brigatinib.
3.Antihypertensive Drugs: Close monitoring of heart rate and blood pressure is advised when co-administered with antihypertensive drugs that may cause bradycardia.
